NeuroStar is a non-invasive FDA-cleared therapy that uses short magnetic pulses to stimulate nerve cells in the area of the brain that controls mood. These pulses can have a lasting effect on the brain’s neurotransmitter levels, helping people suffering from depression achieve long-term remission from depression symptoms. Because NeuroStar is not a drug, it doesn’t cause the side effects that are often associated with antidepressants.
You recline comfortably in a NeuroStar chair during treatment. During a treatment session, precisely targeted magnetic pulses stimulate the mood-regulating areas in the brain that are underactive in people who suffer from depression.There is no anesthesia or sedation. You are fully awake and alert during treatment, and you can resume normal activities immediately after a treatment session.
Yes by most insurances. Call us today to discuss your insurance coverage and treatment options.
Are your customers raving about you on social media? Share their great stories to help turn potential customers into loyal ones.
NeuroStar TMS Therapy is NOT ECT. NeuroStar employs TMS (transcranial magnetic stimulation), which uses magnetic waves similar in strength to magnetic resonance imaging (MRI)
In clinical trials, fewer than 5% of people discontinued treatment due to adverse events. The most common side effect was temporary pain or discomfort at or near the treatment site during therapy that usually resolved within the first week of treatment. There is a rare risk of seizure associated with TMS therapy that occurs in <0.1% of people. NeuroStar TMS therapy has been systematically evaluated for its effects on memory. These clinical trials demonstrated that NeuroStar does not result in any adverse effects on memory or concentration
A typical course of TMS Therapy is 5 times per week for 19-37 minutes sessions, depending on what the doctor determines is the correct protocol, over 4-6 weeks. Any additional treatments are based on clinical judgment.
NeuroStar TMS is the only TMS system with the durability of its effects established over 12 months. In a clinical trial, 2 out of 3 patients who had either responded to treatment or completely remitted their depression symptoms reported 12 months later that they remained at the level they were at the end of the trial. Additionally, after the trial, only 1 in 3 patients needed to return for "maintenance" TMS sessions. Many people’s depression symptoms significantly improve or go away after 4 to 6 weeks of treatment.
It was cleared by the FDA in 2008 to help people fight depression. Today, NeuroStar is the top TMS choice of doctors, and over 4 million treatments have been delivered. Clinical trials have been done which show TMS can treat a range of additional issues including Depression, Anxiety, PTSD, and OCD.